Home
NGHIÊN CỨU LÂM SÀNG
Issue: Số 91+92, 2021
Article
Nguyễn Minh Hiệp: Trung tâm Công nghệ bức xạ, Viện nghiên cứu hạt nhân;
Phạm Thị Bạch Yến: Sở Y tế Lâm Đồng;
Nguyễn Huy Nam: Bệnh viện Phục hồi chức năng Tỉnh Lâm Đồng;
Phan Sỹ Đức: Khoa Sau Đại học, Trường Đại học Đà Lạt;
Nguyễn Trường An: Khoa Sau Đại học, Trường Đại học Đà Lạt;
Nguyễn Văn Phúc: Khoa Sinh học, Trường Đại học Đà Lạt;
Phạm Hồ Thuật Khoa: Khoa Sinh học, Trường Đại học Đà Lạt;
Vũ Bảo Quốc: Khoa Sinh học, Trường Đại học Đà Lạt;
Bùi Chí Bảo: Đơn vị Sinh học Phân tử Di truyền, Bệnh viện Nhi đồng 2, Thành phố Hồ Chí Minh;
Nguyễn Thị Huỳnh Nga: Khoa Sinh học, Trường Đại học Đà Lạt;
Published: August 1, 2020
Views: 60
References
1.
Konno T, Chang S, Seidman JG et al. Genetics of hypertrophic cardiomyopathy. Curr Opin Cardiol 2010; 25: 205 - 209.
2.
TuohyCV,KaulS,SongHKetal. Hypertrophic cardiomyopathy: the future of treatment. Eur J Heart Fail 2020; 22: 228 - 240.
3.
Semsarian C, Ingles J, Maron MS et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015; 65: 1249 - 1254.
4.
Akhtar M, Elliott P. The genetics of hypertrophic cardiomyopathy. Glob Cardiol Sci Pract 2018; 2018: 36.
5.
ChenL,CaiY,ZhouGetal. Rapid Sanger sequencing of the 16S rRNA gene for identification of some common pathogens. PLoS One 2014; 9: e88886.
6.
OchoaJP,LopesLR,Pérez-BarbeitoMetal. Deletions of specific exons of FHOD3 detected by next-generation-sequencing are associated with hypertrophic cardiomyopathy. Clin Genet 2020; doi: 10.1111/cge.13759.
7.
LinthorstGE,HollakCEM. Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations. Ned Tijdschr Geneeskd 2019; 16: D3711.
8.
Sun Y, Man J, Wan Y et al. Targeted next-generation sequencing as a comprehensive test for Mendelian diseases: a cohort diagnostic study. Sci Rep 2018; 8: 11646.
9.
BarbitoffYA,PolevDE,GlotovASetal. Systematic dissection of biases in whole-exome and whole-genome sequencing reveals major determinants of coding sequence coverage. Sci Rep 2020; 10: 2057
10.
ChoiM,SchollUI,JiWetal. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A 2009; 106, 19096 - 19101.
11.
Ng SB, Turner EH, Robertson PD et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009; 461: 272 - 276.
12.
DasoukiM,JawdatO,AlmadhounOetal. Pompe disease: literature review and case series. Neurol Clin 2014; 32: 751 - 776.
13.
Lee DH, Qiu WJ, Lee J et al. Hypertrophic cardiomyopathy in pompe disease is not limited to the classic infantile-onset phenotype. JIMD Rep 2014; 17: 71 - 75.
14.
vanderPloegAT,ReuserAJ. Pompe’s disease. Lancet 2008; 372: 1342 - 1353.
15.
Fukuda T, Roberts A, Plotz PH et al. Acid alpha-glucosidase deficiency (Pompe disease). Curr Neurol Neurosci Rep 2007; 7: 71 - 77.
16.
Salabarria SM, Nair J, Clement N et al. Advancements in AAV-mediated gene therapy for Pompe disease. J Neuromuscul Dis 2020; 7: 15 - 31.
17.
Kishnani PS, Steiner RD, Bali D et al. Pompe disease diagnosis and management guideline. Genet Med 2006; 8: 267 - 288.
18.
RigdenDJ,JedrzejasMJ,deMelloLV. Identification and analysis of catalytic TIM barrel domains in seven further glycoside hydrolase families. FEBS Lett 2003; 544: 103 - 111.
19.
WanL,LeeCC,HsuCMetal. Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II. J Neurol 2008; 255: 831 - 838.
20.
NgiwsaraL,WattanasirichaigoonD,Tim-AroonTetal. Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand. BMC Med Genet 2019; 20: 156.
21.
Ansong AK, Li JS, Nozik-Grayck E et al. Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med 2006; 8: 297 - 301.